BRIEF-Rexahn Says Co And Ocuphire Enter Into Definitive Merger Agreement

June 17 (Reuters) - Rexahn Pharmaceuticals Inc :
   * REXAHN AND OCUPHIRE ENTER INTO DEFINITIVE MERGER AGREEMENT
   * $21.15 MILLION INVESTMENT COMMITTED BY INSTITUTIONAL HEALTHCARE AND ACCREDITED INVESTORS
   * COMBINED CO TO CHANGE NAME TO OCUPHIRE PHARMA AND IS EXPECTED TO TRADE ON NASDAQ CAPITAL MARKET UNDER TICKER SYMBOL "OCUP."
   * FOLLOWING CLOSING, REXAHN WILL ISSUE WARRANTS TO PURCHASE SHARES OF CO'S COMMON STOCK, ADDITIONAL SHARES OF REXAHN COMMON STOCK
   * FOLLOWING MERGER, MINA SOOCH WILL BE APPOINTED COMBINED CO'S PRESIDENT AND CHIEF EXECUTIVE OFFICER

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)